Articles On Resapp Health (ASX:RAP)

Title Source Codes Date
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Stockhead RAP 6 days ago
Check up: A mixed bag for ASX health stocks as FDA decides fates at the flip of a coin

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Stockhead RAP 2 weeks ago
ResApp: Publication of COPD data and new commercial agreement

Digital health company ResApp Health (ASX:RAP) has announced the publication of acute exacerbation of COPD data from its Breathe Easy adult clinical study and a new commercial agreement with Australian-based telehealth company Docto...

BiotechDispatch RAP 3 weeks ago
ScoPo’s Powerplays: Biogen drama, M&A action, and profit-taking coloured the week in healthcare

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Stockhead RAP 1 month ago
Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Stockhead RAP 1 month ago
Why were ASX healthcare shares RAP, BOT and RHT under the spotlight today?

Summary ASX-listed digital health company ResApp Health has recruited the first participant in its US-based trial to assess the link between cough and COVID-19. Botanix Pharmaceuticals revealed encouraging results from the BTX 1204A Pi...

Kalkine Media RAP 2 months ago
Closing Bell: ASX 200 near day’s high after RBA upgrades GDP

The market is trading near day’s high at the close, after the Reserve Bank of Australia’s (RBA) maintained status quo in its latest policy announcement and upgraded the country’s GDP growth estimates. The benchmark index ASX 200 was up 35.5...

Kalkine Media RAP 2 months ago
Here’s why ASX healthcare shares RAP and RCE are on investor’s radar today

Summary Digital health player ResApp Health has entered into a non-exclusive distribution agreement with Ilara Health. Recce Pharmaceuticals stated that RECCE® 327 had shown bactericidal activity against ESKAPE pathogens, including the...

Kalkine Media RAP 2 months ago
Mid-Market: ASX 200 trades high ahead of RBA policy statement, financial shares in red

The Australian share market continued to trade in positive on Tuesday afternoon, owing to favourable global cues, with the benchmark index ASX 200 adding 21.9 points or 0.31% to trade at 7,050. Seven of 11 sectors were trading in green, wh...

Kalkine Media RAP 2 months ago
ResApp (ASX:RAP) share price surges 5% on new agreement

The ResApp Health Ltd (ASX: RAP) share price is racing higher in mid-morning trade. This comes after the company announced a new agreement to accelerate sales in ResAppDx. At the time of writing, the digital health company’s shares are fet...

Motley Fool RAP 2 months ago
Capital Raisings Recap: Nearly $10 billion has already been raised in 2021

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

Stockhead RAP 2 months ago
Telemedicine witnesses a boom amid COVID-19: A look at 3 ASX stocks  

Summary With the current emergency, it is anticipated that telehealth or telemedicine could be the future of medicine. COVID-19 pandemic resulted in considerable adoption of telehealth solutions, mainly to avoid physical contact. The...

Kalkine Media RAP 3 months ago
ScoPo’s Powerplays: Be cautious in May, but check out Volpara

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week With stock...

Stockhead RAP 3 months ago
Why the ResApp (ASX:RAP) share price is down 9% today

The ResApp Health Ltd (ASX: RAP) share price has returned from its trading halt and sunk lower. At the time of writing, the digital health company’s shares are down 9% to 6.2 cents. Why was the ResApp share price in a trading halt? ResApp...

Motley Fool RAP 3 months ago
Last Orders: Sixth straight day of gains for small caps

Small caps have gained for a sixth straight day, even as their larger peers declined. The Small Ordinaries index of Australia’s 101st to 300th biggest companies finished the week up 6.7 points, or 0.2 per cent, to a fresh 13-year high of 3,...

Stockhead RAP 3 months ago
Last Orders: ASX rises again with materials leading the charge

The ASX rose for the fifth day in a row with resources leading the charge. The ASX 200 gained 1.02 per cent closing at 6,999 points while the ASX Emerging Companies Index rose by 0.63 per cent to 2,059. All sectors were in the green but res...

Stockhead RAP 3 months ago
Lunchtime market update: ASX200 at new 52 week high

Source: G-Stock Studio, Shutterstock On Thursday, the market continued its gaining spree. The benchmark index ASX 200 has maintained yesterday's growth momentum. All sectors traded higher today, with Financial leading the gains, followed b...

Kalkine Media RAP 3 months ago
Under the Microscope: Tony Keating, ResApp Health

Morgans analyst Iain Wilkie speaks with Chief Executive Officer and Managing Director of ResApp (ASX:RAP), Tony Keating. Tony provides an update on a number of recent news events.

Morgans RAP 3 months ago
Trading Places: Which fund manager took a $10.5m punt on salmon stock Tassal?

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

Stockhead RAP 4 months ago
Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Stockhead RAP 4 months ago
Why Corp Travel Management, IGO, Limeade, & ResApp are tumbling lower

The S&P/ASX 200 Index (ASX: XJO) is out of form on Wednesday and sinking lower. In afternoon trade, the benchmark index is down a disappointing 0.75% to 6,775.9 points. Four ASX shares that are falling more than most today are listed b...

Motley Fool RAP 4 months ago
ASX stock of the day: Why ResApp Heath (ASX:RAP) shares are soaring

The Resapp Health Ltd (ASX: RAP) share price is soaring today. ResApp shares are up 8.33% at the time of writing to 7.8 cents a share. The company closed at a price of 7.2 cents yesterday but opened at 7.3 cents this morning before rising...

Motley Fool RAP 4 months ago
Why are ResApp (ASX:RAP) shares riding high today?

Source: dindumphoto,Shutterstock Summary ResApp has won a licensing deal from AstraZeneca’s Japanese subsidiary for its cough counting technology. As part of the agreement, ResApp’s technology will be integrated into the asthma manage...

Kalkine Media RAP 4 months ago
ResApp signs second deal with AstraZeneca, sending share price higher by 18pc

ASX medtech play ResApp Health (ASX:RAP) has made further progress on the commercialisation of its medical respiratory technology, announcing today that ... Read More The post ResApp signs second deal with AstraZeneca, sending share price h...

Stockhead RAP 4 months ago
Why Afterpay, Piedmont Lithium, ResApp, & Santos are charging higher

In late morning trade the S&P/ASX 200 Index (ASX: XJO) has followed the lead of US markets and is trading notably higher. At the time of writing, the benchmark index is up 0.8% to 6,765.3 points. Four ASX shares that are climbing more...

Motley Fool RAP 4 months ago
ResApp (ASX:RAP) share price jumps 19% on AstraZeneca deal

The ResApp Health Ltd (ASX: RAP) share price is surging higher after releasing its second announcement in as many days. You can read about the first announcement here. At the time of writing, the digital health company’s shares are up 19%...

Motley Fool RAP 4 months ago
ResApp (ASX:RAP) to initiate study probing the cough-COVID-19 relationship

Source: Guschenkova ,Shutterstock Summary ResApp to develop a smartphone-based algorithm to identify COVID-19 by using cough sound. The Company is confident that the sound identification of COVID-19 will significantly reinforce its of...

Kalkine Media RAP 4 months ago
ResApp (ASX:RAP) share price jumps on COVID-19 app plans

The ResApp Health Ltd (ASX: RAP) share price is surging higher on Thursday. In morning trade the digital health company’s shares are up 5% to 6 cents. Why is the ResApp share price surging higher? Investors have been buying ResApp shares o...

Motley Fool RAP 4 months ago
Why Flight Centre, Qantas, ResApp, & Volpara are racing higher

In late morning trade the S&P/ASX 200 Index (ASX: XJO) has given back its early gains and is tumbling lower. At the time of writing, the benchmark index is down 0.2% to 6,699.7 points. Four ASX shares that are not letting that hold the...

Motley Fool RAP 4 months ago
Why the ResApp (ASX:RAP) share price is sinking 5% today

The ResApp Health Ltd (ASX: RAP) share price is sinking today. This comes after the company announced that Medgate had started European trails for ResAppDx, its smartphone-based acute respiratory diagnostic test. At the time of writing, th...

Motley Fool RAP 4 months ago
Why the ResApp (ASX:RAP) share price opened 10% higher today

Shares in ResApp Health Ltd (ASX: RAP) surged higher on open today after the company announced its wearable device has achieved CE mark certification. In early trade, the ResApp share price leapt 10.53% to 6.3 cents. However, at the time o...

Motley Fool RAP 4 months ago
Why are Emyria (ASX:EMD) & ResApp (ASX:RAP) shares moving north today?

Source: PHOTOBUAY,Shutterstock Emyria Limited (ASX:EMD) announced the addition of its second clinic in Perth for meeting the increasing demand of patients, while digital health company ResApp Health Limited (ASX:RAP) obtained CE mark certi...

Kalkine Media RAP 4 months ago
ResApp Health (ASX:RAP) achieves CE mark for sale of device in Europe

02 Mar 2021 - Digtal health company ResApp Health (ASX:RAP) has achieved CE Mark certification for the company’s wearable device as a Class I medical device accessory.

FNN RAP 4 months ago
FNArena Corporate Results Monitor – 25-02-2021

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AMA)) - Ama Group ((APA)) - APA Group ((APX)) - Appen ((AVG)) - Aust Vintage ((ASG)) - Autosports Group ((BGA)) - Bega Cheese ((BTH)) - Bigtincan Holdings ((BKL)) - Blac...

FNArena RAP 5 months ago
Here’s why the Resapp (ASX:RAP) share price closed 5% lower

The Resapp Health Ltd (ASX: RAP) share price spent today in the red after the company’s 1HY21 results came out this morning. Apparently, investors weren’t impressed with the results and sent ResApp shares down 5.0% to close at 5.6 cents a...

Motley Fool RAP 5 months ago
Why the ResApp (ASX:RAP) share price is climbing higher

The ResApp Health Ltd (ASX: RAP) share price is climbing higher today. This comes after the company provided an update of its prescription-only software application with the United States Food and Drug Administration (FDA). At the time of...

Motley Fool RAP 5 months ago
How did 1H FY21 turn out for Global Health (ASX:GLH)?

Summary Amid growing adoption of digital platforms, Global Health registered a robust half-year performance. Total customer revenue for the period was up by 20% on PCP. The MasterCare platform for community health care providers exper...

Kalkine Media RAP 5 months ago
ResApp receives R&D tax incentive refund and grant

ResApp Health (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, has received a $707,744 R&D tax refund and a $93,994 Export Market Development...

BiotechDispatch RAP 5 months ago
Here’s why the ResApp (ASX:RAP) share price is climbing 6%

ResApp Health Ltd (ASX: RAP) shares are climbing higher today after the company announced it has launched its SleepCheck app on select Android devices. At the time of writing, the ResApp share price is up 6.25% to 8.5 cents. Quick take on...

Motley Fool RAP 6 months ago
Why ResApp Health’s (ASX:RAP) share price surged over 7% in today’s session?

Summary ResApp Health launched its SleepCheck app on select Android devices for the risk assessment of sleep apnoea. The app records and analyses breathing and snoring pattern via the smartphone’s microphone for the data collection. R...

Kalkine Media RAP 6 months ago
ResApp launches apnoea-detecting SleepCheck app on Android

Brisbane-based respiratory health company ResApp (ASX:RAP) has launched an Android version of its sleep apnoea-detecting smartphone app, SleepCheck. The company’s ... Read More The post ResApp launches apnoea-detecting SleepCheck app on And...

Stockhead RAP 6 months ago
Global Health (ASX: GLH): Lifecard Patient Portal demand magnifies

Summary Global Health Ltd (ASX:GLH) said Lifecard Patient Portal is seeing high demand as health delivery organisations have embraced digital engagement with patients. Lifecard Patient Portal assists consumers and doctors in managing d...

Kalkine Media RAP 7 months ago
A snapshot of ASX Quarterly rebalance: Afterpay’s entry into ASX 20 a major highlight

Summary The prominent ASX indices have been rebalanced, effective from 21 December 2020. After the demerger of Iluka Resources from Deterra Royalties, both have been retained in the ASX 200. Afterpay has become one of the 20 most prom...

Kalkine Media RAP 7 months ago
Technology overshadows S&P/ASX rebalance; Afterpay, Xero hit lifetime highs

Summary Only one stock will be removed from the S&P/ASX All Technology Index, while there are thirteen additions.  Australian tech frenzy continues to gain momentum as leaders make all-time highs post rebalance decisions.  S&am...

Kalkine Media RAP 7 months ago
Lens Through 10 Popular ASX-Listed Healthcare Players of 2020

Summary The intensity of adoption of tech-enabled health solutions has shot up amidst government restrictions and infection risks amidst COVID-19. Burgeoning demand for healthcare products kept healthcare stocks under the spotlight in...

Kalkine Media RAP 7 months ago
Why the ResApp (ASX:RAP) share price is edging higher

ResApp Health Ltd (ASX: RAP) shares are edging higher today after the company updated the market on its recent meeting with the United States Food and Drug Administration (FDA) for SleepCheck. In the minutes after market open, the ResApp s...

Motley Fool RAP 8 months ago
Why the Resapp (ASX:RAP) share price stormed 5% higher today

The Resapp Health Ltd (ASX: RAP) share price stormed higher today following the announcement of a new partnership. During afternoon trade, shares in the digital health company reached as high as 9.4 cents, but later pulled back slightly. T...

Motley Fool RAP 8 months ago
Why the ResApp (ASX:RAP) share price is falling 18% lower today

The ResApp Health Ltd (ASX: RAP) share price is sinking lower today following the company’s release of its quarterly update. At the time of writing, the ResApp share price is down 18.18% to 9 cents. Let’s take a look at why shareholders ar...

Motley Fool RAP 8 months ago
Why the ResApp (ASX:RAP) share price is racing higher today

The ResApp Health Ltd (ASX: RAP) share price soared higher today following the release of a positive market announcement. During market open, shares in the digital health company surged to an intra-day high of 12 cents. However, a portion...

Motley Fool RAP 8 months ago
Why the ResApp (ASX:RAP) share price is up almost 20% today

The Resapp Health Ltd (ASX: RAP) share price has stormed higher today following a positive announcement regarding its software. During mid-afternoon, shares in the digital health company reached an intra-day high of 14 cents. Since then, t...

Motley Fool RAP 9 months ago